UA-developed Molecular Imaging Technology Licensed to Lightpoint Medical

A member of the UA faculty has developed a completely new approach to PET imaging that enables the miniaturization of a PET scanner – enabling unprecedented imaging capabilities within the surgical suite.

The University of Arizona has signed an exclusive license agreement for a molecular-imaging technology, Beta Emission Tomography, to Lightpoint Medical of Chesham, England. The technology was originally developed by Dr. Harrison Barrett, Regents’ Professor of Radiology and Optical Sciences, with his student Yijun Ding and colleague Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging in the College of Medicine - Tucson. Lightpoint Medical’s goal is to make PET imaging available in real time to guide cancer surgeries. A member of the UA faculty has developed a completely new approach to PET imaging that enables the miniaturization of a PET scanner – enabling unprecedented imaging capabilities within the surgical suite. The University of Arizona has signed an exclusive license agreement for a molecular-imaging technology, Beta Emission Tomography, to Lightpoint Medical of Chesham, England. The technology was originally developed by Dr. Harrison Barrett, Regents’ Professor of Radiology and Optical Sciences, with his student Yijun Ding and colleague Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging in the College of Medicine - Tucson. Lightpoint Medical’s goal is to make PET imaging available in real time to guide cancer surgeries.